News
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
Notable launches so far this year include the first public-private credit ETF, countless new buffer, covered call, and active ...
Los Angeles has seen a 17.5% reduction in street homelessness in the past year, with the city's Inside Safe initiative and other efforts being credited for the progress, but advocacy groups caution ...
Next City today announces the class of 45 Vanguards who will convene in Philadelphia from October 6 through 9. This is Next ...
Senator Jerry McNerney's SB 846 has been signed into law by Governor Gavin Newsom, aiming to protect California farmworkers ...
The stock market has been reaching new heights in recent weeks. Since their low points in early April, the S&P 500 (SNPINDEX: ...
Foreign bonds may offer U.S. investors better risk-adjusted returns, diversification, and higher yields—if you understand how ...
When Bitcoin ETFs first burst onto the scene in January 2024, there was one major asset management firm that made its disdain ...
Vanguard has long criticized Bitcoin, yet now holds the largest institutional stake in Strategy —a company known for its ...
A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
According to Bloomberg, Vanguard now owns more than 20 million shares of MSTR — over 8% of the company — surpassing Capital Group as the top institutional holder. The stake is worth about $9.26 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results